KRAS NP_004976.2:p.G12R
1 clinical trials · Condition
◉ Watch KRAS NP_004976.2:p.G12R
| Record | Firm | Date |
|---|---|---|
| Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R Mutations (NCT03040986) | National Cancer Institute (NCI) | 2017-07-21 |
Track KRAS NP_004976.2:p.G12R automatically
Every clearance here is in the API, with alerts when new ones post.